Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
H Döhner, E Estey, D Grimwade… - Blood, The Journal …, 2017 - ashpublications.org
The first edition of the European LeukemiaNet (ELN) recommendations for diagnosis and
management of acute myeloid leukemia (AML) in adults, published in 2010, has found …
management of acute myeloid leukemia (AML) in adults, published in 2010, has found …
[HTML][HTML] Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis
Minimal residual disease prior to allogeneic hematopoietic cell transplantation has been
associated with increased risk of relapse and death in patients with acute myeloid leukemia …
associated with increased risk of relapse and death in patients with acute myeloid leukemia …
Association of measurable residual disease with survival outcomes in patients with acute myeloid leukemia: a systematic review and meta-analysis
Importance Measurable residual disease (MRD) refers to neoplastic cells that cannot be
detected by standard cytomorphologic analysis. In patients with acute myeloid leukemia …
detected by standard cytomorphologic analysis. In patients with acute myeloid leukemia …
Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Acute myeloid leukaemia (AML) incidence is age dependent, rising markedly in patients
aged! 60 years. Ageing of the European population may therefore contribute to the reported …
aged! 60 years. Ageing of the European population may therefore contribute to the reported …
Molecular MRD status and outcome after transplantation in NPM1-mutated AML
Relapse remains the most common cause of treatment failure for patients with acute myeloid
leukemia (AML) who undergo allogeneic stem cell transplantation (alloSCT), and carries a …
leukemia (AML) who undergo allogeneic stem cell transplantation (alloSCT), and carries a …